|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/53 | |
| A61K 39/395 |
| (11) | Number of the document | 2773957 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12846452.6 |
| Date of filing the European patent application | 2012-10-29 | |
| (97) | Date of publication of the European application | 2014-09-10 |
| (45) | Date of publication and mention of the grant of the patent | 2017-11-29 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/062430 |
| Date | 2012-10-29 |
| (87) | Number | WO 2013/066818 |
| Date | 2013-05-10 |
| (30) | Number | Date | Country code |
| 201161554924 P | 2011-11-02 | US |
| (72) |
WEIHOFEN, Andreas, CH
ENGBER, Thomas, US
GRIMM, Jan, CH
|
| (73) |
Biogen International Neuroscience GmbH,
Landis & Gyr Strasse 3, 6300 Zug,
CH
|
| (54) | USE OF AN ANTI-ALPHA-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF ALPHA-SYNUCLEIN IN THE BRAIN |
| USE OF AN ANTI-ALPHA-SYNUCLEIN ANTIBODY TO DIAGNOSE AN ELEVATED LEVEL OF ALPHA-SYNUCLEIN IN THE BRAIN |